Publication Name	World Journal of Hepatology
Manuscript ID	89202
Country	China

Received	2023-10-23 15:13
Peer-Review Started	2023-10-23 15:14
To Make the First Decision
Return for Revision	2023-11-22 23:34
Revised	2023-11-27 08:40
Second Decision	2023-12-05 09:08
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-12-12 07:54
Articles in Press	2023-12-12 07:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-12-15 06:34
Publish the Manuscript Online	2023-12-25 06:03

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
Manuscript Source	Invited Manuscript
All Author List	Li Chen
Funding Agency and Grant Number
Corresponding Author	Li Chen, Doctor, MD, PhD, Doctor, Doctor, Department of Gastroenterology, Ruijin Hospital , Shanghai JiaoTong University, School of Medicine, No. 999 Xiwang Road, Jiading District, Shanghai 201801, China. drchenli@163.com
Key Words	Non-alcoholic fatty liver disease; Metabolic dysfunction-associated fatty liver disease; Metabolic dysfunction-associated steatotic liver disease; Nomenclature; Metabolic risk factors
Core Tip	The nomenclature for non-alcoholic fatty liver disease has undergone name changes twice in a span of three years. However, there exist significant disparities and some consensus between the transition from metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease. Clarifying these discrepancies would greatly benefit clinical practice and trials.
Publish Date	2023-12-25 06:03
Citation	Chen L. From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus. World J Hepatol 2023; 15(12): 1253-1257
URL	https://www.wjgnet.com/1948-5182/full/v15/i12/1253.htm
DOI	https://dx.doi.org/10.4254/wjh.v15.i12.1253

Full Article (PDF)	WJH-15-1253-with-cover.pdf
Full Article (Word)	WJH-15-1253.docx
Manuscript File	89202_Auto_Edited-LJH-YJP.docx
Answering Reviewers	89202-Answering reviewers.pdf
Audio Core Tip	89202-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	89202-Conflict-of-interest statement.pdf
Copyright License Agreement	89202-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	89202-Language certificate.pdf
Peer-review Report	89202-Peer-review(s).pdf
Scientific Misconduct Check	89202-Bing-Liu JH-2.png
Scientific Misconduct Check	89202-CrossCheck.png
Scientific Editor Work List	89202-Scientific editor work list.pdf
CrossCheck Report	89202-CrossCheck report.pdf